Skip to content

13F-HR filed by Darwin Global Management, Ltd.

Darwin Global Management, Ltd. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:08:37 UTC, with 5 holding rows worth $3,991,376,206.

Accession
0001892688-26-000178
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

13F report for Q3 2026

A holdings report, 5 entries on the cover page, a total value of $3,991,376,206 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,991,376,206 with VALUE read as dollars as filed, 13F file number 028-21006. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
REVOLUTION MEDICINES INC COM76155X100Stock10,629,822$2,181,877,264dollars as filed
GENMAB A/S372303206Ordinary Shares, nominal value DKK 1 per share17,899,876$638,578,076dollars as filed
BELITE BIO INC07782B104CMN3,097,132$525,954,956dollars as filed
ABIVAX SA-00370M103SPONSORED ADS4,021,583$398,217,149dollars as filed
ROIVANT SCIENCES LTDG76279101SHS6,747,300$246,748,761dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001892688-26-000178this filing2026-11-16